Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Similar documents
Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Diagnostic and Prognostic Value of Coronary Ca Score

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Current and Future Imaging Trends in Risk Stratification for CAD

New Paradigms in Predicting CVD Risk

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

Khurram Nasir, MD MPH

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

Potential recommendations for CT coronary angiography in athletes

Coronary Artery Calcification

Is computed tomography angiography really useful in. of coronary artery disease?

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Carotid Ddisease, Carotid IMT and Risk of Stroke

Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Learn and Live SM. ACCF/AHA Pocket Guideline

Welcome! To submit questions during the presentation: or Text:

Testing the Asymptomatic CAD Patient: When and Why?

Cardiac CT Angiography

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH

Risk Assessment for Primary Prevention

I have no financial disclosures

MD F A F C A C MAS A N S C

Calcium scoring Clinical and prognostic value

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Advanced Imaging MRI and CTA

CARDIAC IMAGING FOR SUBCLINICAL CAD

Imaging-Guided Statin Allocation: Seeing Is Believing

FFR-CT Not Ready for Primetime

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Who Cares About the Past?

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

UNITED STATES AIR FORCE AEROMEDICAL UPDATE AND REVIEW FOR AVIATORS WITH KNOWN CORONARY ARTERY DISEASE

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics

BENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES

Risk Stratification for CAD for the Primary Care Provider

Global: Polypill Selective: Imaging

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Learning Objectives. Predicting and Preventing Cardiovascular Disease. ACC/AHA Cholesterol Guidelines Key differences vs ATP III

CVD risk assessment using risk scores in primary and secondary prevention

CT Coronary Angiography - Indications: From the guidelines to clinical practice

Coronary Artery Calcium: Absence Makes the Heart Younger?

Disclosure Information

Imaging of Coronary Arteries Aid in Prevention of Atherosclerosis and Clinical Coronary Heart Disease

Cardiology Update 2011 Davos February 2011

Defining Severe Familial Hypercholesterolemia. Raul D. Santos MD, PhD Brazil

Physiologic Assessment by Cardiac CT

Dr Chris Ellis. Consultant Cardiologist Auckland

Stress Testing:Which Study is Indicated for My Patient?

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Medical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification

When Should I Order a Stress Test or an Echocardiogram

Calcium Scoring and Cardiac CT

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Best Lipid Treatments

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

Diabetes and Occult Coronary Artery Disease

Coronary Artery Calcium Score

Keywords Coronary artery calcium Coronary artery atherosclerosis Coronary risk assessment Coronary artery CT

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Computed Tomography to Detect Coronary Artery Calcification. Original Policy Date

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Stress only Perfusion Imaging

Vascular calcification in patients with Diabetes Mellitus. Dr Jamie Bellinge University of Western Australia Royal Perth Hospital

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Sanger Heart & Vascular Institute Symposium 2015

Coronary Artery Calcium Scanning Should be Used for Primary Prevention

2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS

Effective for dates of service on or after April 1, 2013, refer to:

Does medicare cover ct heart calcium scoring

Reducing the Population Health Burden of Cardiovascular Disease

Practical challenges in CV risk management: When to start intervening in CVD?

Assessing atherosclerotic risk for long term preventive treatment

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Although the burden of cardiovascular disease. Prognostic Value of Coronary Artery Calcium Screening. CLinical review

Kavitha Yaddanapudi Stony brook University New York

Supplementary Online Content

Characteristics of Subclinical Coronary Artery Disease in Diabetic Patients without Known Coronary Artery Disease

Transcription:

Coronary Artery Calcium Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Disclosures I have no conflicts of interest to disclose.

Objectives Recognize the utility of coronary artery calcium scoring in CV risk stratification Understand the diagnostic modality of CACS and how results affect patients Implement appropriate diagnostic and therapeutic steps with CACS results

Outline I. CAD and calcific plaquing II. CV risk reclassification III. Coronary artery calcium score IV. Therapeutic implications

CAD and Calcific Plaquing CHD remains the leading cause of death worldwide CHD accounts for 1 out of 3 deaths in US adults > 35 years 41% increase in CV related deaths since 1990 Total CV Death Rate per 100,000 CDC, 2013-2015.

Murabito, Circulation. CAD: Diagnosis often comes too late

Fuster & Sanz, JACC. High Prevalence of Subclinical Plaque

Sandfort, Circulation. CAD and Calcific Plaquing

Cardiovascular Risk Stratification Global risk factor scores address only conventional factors Age, diabetes, elevated LDL, low HDL, HTN, tobacco use, family history CACS demonstrates a very high NRI when compared to other risk markers High NRI - % patients with FRS estimate that were correctly reclassified by CACS: 52 to 66% in intermediate risk group 34 to 36% in high risk group 12 to 15% in low risk group Hecht, JACC.

CACS Adds Value Regardless of Other Risk Factors

Hecht, JACC. Cardiovascular Risk Stratification

Hecht, JACC. Cardiovascular Risk Stratification

Cumulative Survival CACS Strongly Associated with CV Death 1.00 0.95 0 (n=11,044) 1-10 (n=3,567) 11-100 (n=5,032) 101-299 (n=2,616) 0.90 300-399 (n=561) 0.85 0.80 400-699 (n=955) 700-999 (n=514) 0.75 0.70 2 =1363, p<0.0001 for variable overall and for each category subset. 1,000+ (n=964) Budoff, JACC. 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Time to Follow-up (Years)

Indications for CAC Assessment Asymptomatic adults with intermediate risk (10-20% 10 year risk) Class IIA, LOE B Asymptomatic adults with low to intermediate risk (6-10% 10 year risk) Class IIB, LOE B Asymptomatic adults with diabetes Class IIA, LOE B Low risk (< 6% 10 year risk) should not undergo CAC measurement Class III, LOE B ACCF/AHA Guidelines, 2010 & 2013

Coronary Artery Calcium Scan Ambulatory non-contrast CT scan with limited FOV 3 to 5 second breath hold Low radiation exposure < 1 msv (<< 1 msv with newer systems) Nearly equal to radiation from a mammogram Approximate radiation from living in a big city x 3 months Costs less than most tests that are covered ($59 out of pocket) Immediate printed results given to patient Printed report tells referring provider what percentile via MESA

Blaha, JACC.

Coronary Artery Calcium Scan 0 = No identifiable calcium 1-99 = Mild disease 100-399 = Moderate disease 400 = Severe disease

Coronary Artery Calcium Scan Calcium = presence of atherosclerosis, but atherosclerotic lesions do not always contain calcium Calcium may occur early in life, and not necessarily in functionally significant lesions (i.e. significant stenosis) CAC of 0 = very protective = < 1-2% chance of CV event next 10 yrs CAC > 0 CAD is unequivocally present Even low score of 1-10, confers a significant risk of CV events High (>100) and very high (>400) are proportionally associated with more risk

Berman, JACC. CAC Score and MPI Result

Hecht, JACC.

Therapeutic Implications CACS > 0 confers greater risk of CV events, therefore ideal to initiate: Aspirin 81mg PO daily Statin therapy *Irrespective of lipid level CAC > 100 confers high risk of CV events Careful clinical assessment Consider stress testing (? Functional stenosis) If initial CACS = 0, consider repeat scan no earlier than 5 years

Thank You Email: vramjee@chattanoogaheart.com Phone: (973) 960-7188 Don t hesitate to reach out!

Likelihood of CAD based on Risk Factor

DIAGNOSTIC SENSITIVITY NON-INVASIVE MODALITIES STRESS ECG $300 STRESS ECHO $900 STRESS THALLIUM $1600 PET SCANNING $2200 Coronary Calcium with CT $295 $59 INTRAVASCULAR ULTRASOUND $3,000 INVASIVE MODALITIES CORONARY ANGIOGRAPHY $5,000 0% 20% 45% 60% 70% 90% DATA TAKEN FROM THE DAWN OF A NEW ERA - NON-INVASIVE CORONARY IMAGING R. ERBEL HERZ 1996; 21, 75-77